Table 3.
Risk of Vertical Transmission by Route, and Odds Ratios for Study and Risk Group
| Route and Risk Group | Posterior Median | Credible Interval | |
|---|---|---|---|
| 2.5% | 97.5% | ||
| Risk of transmission, %, by route | |||
| ȃEarly in utero | 1.38 | .64 | 2.59 |
| ȃLate in utero | 3.88 | 2.24 | 5.87 |
| ȃDelivery | 0.38 | .03 | 1.97 |
| Odds ratios, by study | |||
| ȃEPHN | 1 (ref) | … | … |
| ȃBPSU | 1.23 | .64 | 2.20 |
| ȃALHICE | 0.98 | .47 | 1.87 |
| Odds ratios, by risk group | |||
| ȃHIV−, low VL | 1 (ref) | … | … |
| ȃHIV−, high VL | 2.66 | 1.19 | 6.12 |
| ȃHIV+, low VL | 1.75 | 1.08 | 3.12 |
| ȃHIV+, high VL | 3.43 | 1.69 | 8.03 |
Abbreviations: ALHICE, Alpes-Maritimes, Languedoc, Haute Garonne Infection C chez l’Enfant; BPSU, British Paediatric Surveillance Unit; EPHN, European Pediatric HCV Network; HIV, human immunodeficiency virus; VL, viral load.